NCT07769034

Brief Summary

This randomized, sham-controlled, parallel-group clinical trial aims to investigate whether the timing of transcutaneous auricular vagus nerve stimulation (taVNS) relative to therapeutic exercise influences pain intensity, disability, autonomic function, and motor performance in individuals with chronic neck pain. A total of 81 participants will be randomly assigned to one of three groups: active taVNS before exercise and sound-sham stimulation after exercise (PRE), sound-sham stimulation before exercise and active taVNS after exercise (POST), or sound-sham stimulation both before and after exercise (CONTROL). All participants will complete a standardized supervised exercise program three times per week for six weeks. The study will use a double-dummy approach to standardize intervention procedures across groups and support blinding. The primary outcome will be neck pain intensity assessed using the Numeric Pain Rating Scale (NPRS). Secondary outcomes will include neck-related disability, heart rate variability, pressure pain threshold, exercise-induced hypoalgesia, and deep cervical flexor motor performance assessed using the craniocervical flexion test.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Nov 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

November 15, 2026

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

October 23, 2026

Status Verified

October 1, 2026

Enrollment Period

8 months

First QC Date

August 12, 2026

Last Update Submit

October 20, 2026

Conditions

Keywords

CHRONIC PAINVAGAL NERVE STIMULATIONEXERCISE

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Intensity - Numeric Pain Rating Scale

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Participants will rate their neck pain on an 11-point scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores indicate greater pain intensity. Change from baseline will be compared between groups.

    Baseline and immediately after completion of the 6 week interventions

Secondary Outcomes (7)

  • Exercise Adherence

    Throughout the 6-8-week intervention period.

  • Change in Heart Rate Variability - RMSSD

    Baseline and immediately after completion of the 6 weeks intervention.

  • Change in Neck-Related Disability - Neck Disability Index

    Baseline and immediately after completion of the 6 weeks interventions.

  • Change in Sleep Quality - Pittsburgh Sleep Quality Index

    Baseline and immediately after completion of the 6 weeks intervention.

  • Change in Pressure Pain Threshold (PPT)

    Baseline and immediately after completion of the 6 weeks intervention.

  • +2 more secondary outcomes

Study Arms (3)

PRE-taVNS

EXPERIMENTAL

Participants receive active taVNS before standardized therapeutic exercise and sound-sham stimulation after exercise, three times weekly for six weeks.

Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Other: Exercise Program

POST-taVNS

EXPERIMENTAL

Participants receive sound-sham stimulation before standardized therapeutic exercise and active taVNS after exercise, three times weekly for six weeks.

Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Other: Exercise Program

CONTROL

SHAM COMPARATOR

Participants receive sound-sham stimulation both before and after standardized therapeutic exercise, three times weekly for six weeks.

Other: Exercise ProgramDevice: Sound-sham taVNS

Interventions

Transcutaneous auricular vagus nerve stimulation will be delivered non-invasively through an auricular stimulation device targeting the auricular branch of the vagus nerve. Stimulation will be administered under researcher supervision using standardized stimulation parameters according to the device instructions and study protocol.

POST-taVNSPRE-taVNS

Participants will perform a standardized exercise program for chronic neck pain including postural correction, deep cervical flexor activation, cervical mobility, scapular stabilization, and stretching exercises. Exercises will be performed under researcher supervision during the intervention period.

CONTROLPOST-taVNSPRE-taVNS

Sound-sham transcutaneous auricular vagus nerve stimulation (taVNS) will be administered using a sham configuration of the Nurosym device (Parasym Scientific Ltd., UK). The sham procedure will replicate the appearance, electrode placement, duration, and auditory cues of active taVNS without delivering electrical stimulation. The device will produce acoustic signals mimicking those associated with active stimulation, while no electrical current will be delivered through the auricular electrodes. Each sham session will last 30 minutes. This procedure

CONTROL

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic neck pain confirmed by a physical medicine and rehabilitation physician.
  • Age between 18 and 65 years.
  • Neck pain persisting or recurring for at least 3 months.
  • Ability to participate in the exercise program included in the study protocol.
  • No contraindication to transcutaneous auricular vagus nerve stimulation.
  • Willingness to provide written informed consent.
  • Willingness to participate regularly in the planned exercise and assessment sessions.

You may not qualify if:

  • Cervical radiculopathy or specific neurological findings.
  • Previous cervical spine surgery.
  • Serious cardiovascular disease.
  • Serious neurological or systemic disease.
  • Pregnancy.
  • Orthopedic or musculoskeletal conditions preventing participation in exercise.
  • Cognitive or communication problems that prevent completion of the assessment instruments.
  • Inability or unwillingness to comply with the study protocol or attend scheduled sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University Physical Therapy and Rehabilitation Research Center

Kütahya, Türkiye, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Chronic PainMotor Activity

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Batuhan YUKSEL, Msc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A double-dummy design will be implemented in which all participants receive device-based stimulation procedures both before and after exercise. Active taVNS and sound-sham stimulation will be administered using visually similar, coded electrode configurations. Participants and outcome assessors will remain blinded to group allocation. Blinding of intervention providers will also be maintained if the device coding and administration procedures permit. Allocation information will be managed by an independent researcher not involved in outcome assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 12, 2026

First Posted

August 17, 2026

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

October 23, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Locations